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Abstract
Ménière’s disease (MD) is a progressive inner ear disorder that affects at least 0.2% of the 
population in EUA. The symptoms triad of fluctuating hearing loss, tinnitus, and vertigo 
was described by Prosper Ménière for more than a century and its pathophysiology is 
still unknown. MD has a fluctuating course and in many cases, difficult clinical man-
agement. Progressive hearing loss and intense dizzying seizures becomes more frequent 
as the disease progresses. All of this increases the challenges of accurate identification 
and has probably led to the trial of several tests for identifying MD. The tests are useful 
tools to assist the otolaryngologist both in diagnosis and prognosis of MD. These tests 
includes audiometry, otoacustic emission (OAE), electrocochleography (EcochG), vestib-
ular evoked  myogenic potentials (VEMP), cochlear hydrops analysis masking procedure 
(CHAMP) and video head impulse test (vHIT).
Keywords: Meniere’s disease, endolymphatic hydrops, electrocochleography, VEMP, 
CHAMP, vHIT
1. Introduction
Ménière’s disease (MD) is a progressive inner ear disorder that affects at least 0.2% of the 
population in EUA [1]. The symptoms triad of fluctuating hearing loss, tinnitus, and vertigo 
was described by Prosper Ménière for more than a century and its pathophysiology is still 
unknown.
For a long time, it was believed that endolymphatic hydrops would be the histopathological 
substrate of the disease. The cause of hydrops is still unknown and most of the theories are 
based on altered endolymph production or reabsorption. The hydrops occurs more often in 
the cochlea and saccule, followed by the utricle and semicircular channels [2]. Recent stud-
ies have indicated that hydrops is a finding of the MD, together with the symptoms, since it 
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alone does not explain all the clinical features, including the progression of hearing loss and 
the frequency of vertigo attacks [3].
According to the criteria of the Bárány Society, MD is classified as definite or probable. In 
definite MD, the patient should have had two or more spontaneous episodes of vertigo, each 
lasting from 20 min to 12 h, documented mild to moderate sensorineural hearing loss, aural 
symptoms (hearing, tinnitus, and fullness) in the affected ear, and exclusion of other vestibu-
lar disorders that explain the symptoms. In probable MD, the patient should have had two 
or more episodes of vertigo or loss of balance, each lasting from 20 min to 24 h, floating aural 
symptoms (hearing, tinnitus, or fullness) in that ear, and exclusion of other vestibular disor-
ders that explain the symptoms [4].
MD has a fluctuating course and in many cases difficult in clinical management. Progressive 
hearing loss becomes more frequent and intense dizzying seizures as the disease progresses. 
All of this increases the challenges of accurate identification, and has probably led to the trial 
of several tests for identifying MD. The tests are useful tools to assist the otolaryngologist both 
in diagnosis and prognosis of MD. Identify the site of hydrops, even in cases of severe hear-
ing loss and possible involvement of the asymptomatic ear are useful information on disease 
management.
These tests includes tonal and speech audiometry /impedance, otoacustic emissions (OAE), 
electrocochleography (EcochG), vestibular evoked  myogenic potentials (VEMP), cochlear 
hydrops analysis masking procedure (CHAMP) and video head impulse test (vHIT).
2. Electrophysiology
2.1. Tonal and speech audiometry/Impedance
Audiometry is helpful to confirm the diagnosis and it is a part of the criteria of the Bárány 
Society. In the early stages of the disease, there is a low frequency sensorineural hearing loss 
that fluctuates in time. In some cases, it also affects high frequency, setting the pattern of 
inverted U. In later stages, the hearing loss would increase and the audiogram would become 
more and more flat. Sometimes, a decreased speech discrimination is also mentioned as a 
common symptom of MD [5]. Hearing loss initially resolves after attacks, but with the disease 
progression, patients may experience loss of auditory nerve fibers. The impedance is helpful 
to exclude middle ear pathology.
2.2. Otoacoustic emission (OAE)
Otoacoustic emissions are subliminal sounds detected in the external auditory canal and gen-
erated by the outer hair cells. They are useful in the diagnosis of many cochleopathies, includ-
ing MD.
Authors believe that hydrops causes changes in the hydrodynamic and cochlear biomechani-
cal micromechanism, due to changes in the interciliary bridges caused by the distension of 
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membranes and cells within the cochlear duct. These changes could affect the transmission 
of the stimulus by outer hair cells, but not necessarily loss of them. The selective atrophy of 
the short and medium stereocilia at the cochlea’s apex is correlated with the hearing loss in 
low frequencies that occur in the early phase of MD. The OEA can reveal early lesions due 
to alterations of the cochlear micromechanism not correlated with the auditory thresholds 
detected in tone audiometry [6].
The distortion product otoacoustic emission (DPOAE) was considered more appropriate than 
transient otoacoustic emission (TEOAE) for monitoring during glycerol test because of its 
high sensitivity in the detection of changes in cochlear function. DPOAE is a complementary 
test to pure tone audiometry during the glycerol test. It is very useful and will improve the 
diagnosis of endolymphatic hydrops [7].
2.3. Electrocochleography (EcochG)
Electrocochleography records the three mechanoelectrical potentials of the cochlea. The 
cochlear microphonic is considered the first step to the neural impulse. It reflects the sum of 
the intracellular potentials generated in the hair cells of the basal portion of the cochlea dur-
ing depolarization [8]. Hall in 2007, Durrant, Ding and Salvi in 1998, affirm that the inner hair 
cells play a central role in the generation of SP, while other authors, such as Burkand et al. 
believe that it is generated by both internal and external hair cell [8–10]. Action potential (AP) 
is the sum of the synchrony of individual neural APs of the cochlear nerve.
Electrocochleography is the test capable of measuring endolymphatic hydrops in the cochlea. 
The test is usually performed with a transthympanic or extrathympanic electrode (Figure 1). 
Hydrops changes the mechanical properties of the cochlea, leading to asymmetric movements 
of the basilar membrane, which may exacerbate the SP, and consequently, increases the ratio 
between the amplitudes of SP and AP. The increase in SP amplitude will change according to 
the existing pressure and volume of the intralabirintic fluid [10, 11] (Figure 2).
The SP/AP ratio thresholds are variable in the literature. Pappas et al. believe that any result 
above 0.5 in an extratympanic EcochG is suggestive of endolymphatic hydrops [12], while 
Iseli and Gibson established a value of 0.33 in a transtympanic EcoghG [13].
Lamounier et al. in a systematic review reported that in 25–54% of patients with MD, the 
electrocochleography presented normal results, with the sensitive of the test ranging from 57 
to 71% and a specificity ranging from 92 to 96%. In most studies selected, the transtympanic 
electrode is the most widely used. EcochG  in MD presents a variable sensitivity, as in cases of 
hearing loss due to disease progression, patients may experience a reduction in the amplitude 
of AP due to loss of auditory nerve fibers [14–17].
On comparing the results of the transtympanic and extratympanic electrocochleography in 20 
patients with Ménière's disease and 20 control patients, Ghosh et al. reported a significant dif-
ference between the SP/AP ratios of the cases and control groups. For an SP/AP ratio of 0.29, 
they found 100% sensitivity, 90% specificity to transtympanic, and 90% and 80% to the extra-
tympanic EcochG, respectively, and concluded that extratympanic EcochG is a non-invasive 
method, effective and easier to carry out in clinical practice than transtympanic EcochG [15].
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Lamounier et al. also found in the systematic review that the analysis of the SP/AP ratio curve 
of the transtympanic electrocochleography did not necessarily increase sensitivity in the diag-
nosis of hydrops when compared with the SP/AP amplitude [14, 16–18].
Gibson et al. compared EcochG results in ears with Ménière’s disease and healthy ears with 
similar hearing loss and concluded that click SP/AP measurements are not helpful in making 
this differentiation but that tone burst SP amplitude measurements were significantly differ-
ent between these populations [19].
Colon and Gibson showed that the sensitivity of transtympanic electrocochleography increased 
to 85% when 1 kHz of tone burst was used to measure SP. They reported that the majority of 
Figure 1. Position of  EcochG´s electrodes.
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 specialists or 58.6%, use click stimuli as opposed to 17.2%, who use tone burst, and 24.3% who use 
both stimuli [20]. Lopes et al. evaluated the sensitivity and specificity of the SP/AP ratio and graphic 
angular measurement in electrocochleographies of 71 ears of 41 MD patients and 14 normal-hear-
ing control patients. They concluded that the graphic angular measurement is not sensitive or spe-
cific enough to diagnose MD. The association of the SP/AP ratio and graphic angular measurement 
in conjunction improved the sensitivity to the detriment of the specificity of the test [21].
Electrocochleography is a valuable tool in the diagnosis of cochlear hydrops, as it is noninva-
sive, easy to handle, and offers new techniques to increase the sensitivity of the test.
2.4. Vestibular evoked myogenic potentials (VEMP)
Vestibular evoked myogenic potentials (VEMP) emerged as a recent and complementary way 
of vestibular system assessment with the specific analysis of the saccular function and inferior 
vestibular nerve.
In 1992, Colebatch and Halmagyi proposed that the saccular macula was the peripheral receptor 
of the vestibular-spinal reflex and in 1994 reported surface potential in the sternocleidomastoid 
(SCM) muscle in response to clicks through high-intensity air conduction (100 dB), accessing the 
Sacculo-collic reflex [22].
VEMP is, therefore, a short latency myogenic response, generated after a sound stimulus, origi-
nating in the sacculo and conducted by the inferior division of the inferior vestibular nerve to the 
central nervous system, generating inhibitory electrical responses captured by surface electrodes 
on the muscles, during muscular contraction. This neural response is a reflex arc of three neurons 
that surround the inner ear, the brainstem, and the  vestibular-spinal pathway [22–24] (Figure 3).
Figure 2. EcochG.
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Similar myogenic responses have been captured in other muscle groups. The responses cap-
tured in SCM are called cervical VEMP (cVEMP) and those collected in the extraocular mus-
culature are called ocular VEMP (oVEMP). VEMP can be obtained by air and bone conduction 
and galvanic stimulation, using tone burst or clicks stimulus [23–25] (Figure 4).
The electrical responses of these potentials consist of two biphasic waves, the first negative 
wave, with latency around 13 ms, known as p13. This is followed by another wave, this 
time positive, with latency around 23 ms, known as n23. There is also a second biphasic 
complex known as n34-p44, but due to the lack of replicability of this second complex, only 
the first complex is considered. The electromyographic potential recording waves are usu-
ally defined by: latency, wave morphology, peak-to-peak amplitude, or the difference in 
values between the most positive point of one wave and the most negative point of another 
wave [26] (Figure 5).
The large variation in the amplitude of the responses, due to the different degrees of mus-
cular contracture obtained for each individual, justifies the analysis of the VEMP responses 
through the interaural asymmetry index. The literature review showed that VEMP is con-
sidered altered by the absence of reproducible waves and or asymmetry index of interaural 
responses greater than 34% [26].
Figure 3. Neural pathway of VEMP.
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The cVEMP is more sensitive for deep bass. Stimuli with frequencies near 500 Hz have higher 
response amplitudes. Air conducted (AC) sound is the most commonly used stimulus for 
eliciting cVEMPs. Tone bursts are preferable above clicks because the latter have less reliable 
results and need higher absolute intensities to evoke a response [26].
The cVEMP is absent or decreased by 30–54% in patients with MD [22, 23]. It may be 
increased in the early stages of MD, perhaps by the pressure of saccular hydrops against 
the stapes footplate, increasing sensitivity sacular to intense sound. Its measurement may 
be floating, with a tendency to disappear with the progression of the disease, as well as 24 h 
post-crisis, which may reappear after 48 h or with the use of drugs to reduce endolymphatic 
hydrops [25–27].
Figure 4. Position of cervical VEMP´s electrodes.
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Figure 5. VEMP ´s waves.
Lamounier et al. evaluated the sensitivity and specificity of VEMP and EcochG in the diagnosis 
of definite MD compared with the clinical diagnosis. The study includes 12 patients (24 ears) 
diagnosed with definite MD defined according to the clinical criteria proposed by the American 
Academy of Otolaryngology Head and Neck Surgery (AAO-HNS) in 1995, as well as 12 healthy 
volunteers allocated to the control group (24 ears). A clinical diagnosis by the AAO-HNS criteria 
was considered as the gold standard. All patients underwent an otoneurological examination, 
including pure tone and speech audiometry, cVEMP and extratympanic EcochG. The sensitiv-
ity and specificity to detect the presence or absence of disease were calculated. In both tests and 
in both ears, the ability to diagnose healthy cases was high, with specificity ranging from 84.6 
to 100%. Moreover, the ability of the tests to diagnose the disease varied from low to moderate 
sensitivity, with values ranging from 37.5 to 63.6%. The agreement of both tests in the right ear, 
measured by the kappa coefficient, was equal to 0.54 indicating a moderate agreement. In the 
left ear, that agreement was equal to 0.07 indicating a weak correlation between the tests. The 
sensitivity of the VEMP for the right ear was 63.6% and for the left ear, 62.5%. The sensitivity of 
EcochG for the right ear was 63.6% and 37.5% for the left ear. They concluded that the specificity 
of both tests was high, and the sensitivity of VEMP was higher than that of EcochG [3].
Similar to cVEMPs, oVEMPs can also be augmented in MD [28].
The ocular VEMP (oVEMP) is a more recently described reflex, which is thought to reflect pre-
dominantly utricular otolith function and can be understood as part of the vestibulo-ocular 
reflex (VOR). Patients with MD have higher rates of attenuated or absent oVEMPs than nor-
mal subjects, increasing with advancing disease [28–30].
Wen et al. recruited unilateral MD patients with either augmented or reduced oVEMPs (asym-
metry >40 and <100%) in response to bone-conducted vibration and found that augmented 
oVEMPs were seen more frequently in patients with early stage MD. Augmented responses 
might also be more likely when recorded during an attack [31].
Winters et al. examined air-conducted oVEMPs in MD patients and found lower response rates 
with smaller amplitudes and higher thresholds compared to normal subjects. Interestingly, 
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this effect was observed not only in the affected, but to a lesser extent also in the clinically 
unaffected ears [32].
The VEMP is easy to perform, does not cause discomfort to patient and does not vary with 
hearing loss. The ability to predict the presence of abnormalities in an asymptomatic ear is 
one of the great features of VEMP [33].
2.5. Cochlear hydrops analysis masking procedure (CHAMP)
The cochlear hydrops analysis masking procedure (CHAMP) was introduced in 2005 as a new 
test to diagnose MD. Don et al. showed that endolymphatic hydrops in patients diagnosed 
with MD causes changes in the response properties of the basilar membrane that lead to 
impaired high-pass noise masking of auditory brainstem response (ABR) to clicks in staked 
ABR. The latency delay in normal-hearing ears, between wave V for the click alone response 
and the 0.5 kHz high-pass masking noise condition, is significantly longer than that in MD 
ears. This difference is known as the latency delay [34].
The increased velocity of the traveling wave would affect the properties of the basilar mem-
brane but cannot affect the tonotopic organization along the basilar membrane. The increased 
velocity of the traveling wave is more likely to impact the low frequencies as they are repre-
sented toward the apical end on the basilar membrane. When ABR latencies are obtained by 
presenting clicks along with the high-pass masking noise in individuals with Méniére’s dis-
ease, the altered motion mechanics of the basilar membrane limits the ability of low-frequency 
noise to mask the activity in high frequency [35, 36] (Figure 6).
Figure 6. CHAMP.
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In individuals with MD, we can observe the phenomenon of undermasking in high-pass 
responses, whereas the undermasking phenomenon is not seen in normal individuals. This 
would in turn result in lesser latency difference between click alone and click with 500 Hz 
high-pass masking noise condition in ears with MD than unaffected or normal ears [37].
Don et al. conducted the test in 23 definite MD patients and compared the results with 38 non-MD 
normal-hearing subjects. Their measures did not demonstrate an overlap between the Ménière’s 
and nonMénière’s groups, and therefore, the authors concluded that the test had an extremely 
high, even 100%, sensitivity and 100% specificity for diagnostic use in individual patients [34].
However, some studies have questioned these findings by reporting significantly lower sen-
sitivity and specificity values. De Valck et al. evaluated CHAMP performance in Ménière 
patients and normal controls, and revealed no discriminative value in differentiating 
Ménière’s from non-MD subjects with otovestibular symptoms [37].
Kingma investigated the usefulness of the cochlear hydrops analysis masking procedure 
(CHAMP) as an additional diagnostic test in patients with definite unilateral Ménière’s dis-
ease. With less than 0.3 ms criterion and including the ears in which no delay could be mea-
sured, the sensitivity of the CHAMP is 32% and concluded that abnormal latency delays for 
CHAMP are delays shorter than 2 ms. Earlier results with CHAMP should be reconsidered 
using this criterion, instead of 0.3 ms [38].
Lee et al. suggest that the CHAMP seems to be more valuable in detection of definite MD than 
is extratympanic EcochG [39].
Furthermore, CHAMP can only be recorded for losses not exceeding moderate degree, which 
limits its use to identify Meniere’s disease with lesser degree of hearing losses only.
The literature indicates a need for continued exploration of these tests in order to establish the 
usefulness or lack of it in the diagnosis for MD.
2.6. Video head impulse test (vHIT)
A new quantitative test of vestibular function known as the video head impulse test (vHIT) 
has recently emerged that now allows for discrete measurements of the vestibulo-ocular 
reflex (VOR) during evaluation of the extremely high-frequency head movements. Although 
the bithermal caloric test is useful for assessing low-frequency vestibular system function, the 
head impulse test (HIT), as described by Halmagyi and Curthoys, is a method for testing the 
function in a frequency region encountered in everyday life in the vestibular system [40, 41].
The primary differences between the vHIT and caloric tests are the mode of stimulus delivery 
(thermal gradient vs. natural head motion) as well as the temporal frequency of each exami-
nation (caloric stimulus represents a low-frequency stimulus and the vHIT a high-frequency 
stimulus). It is well known that the vHIT and caloric tests are sensitive to detection of a certain 
percentage of patients with MD [42, 43].
The test involves examiner-initiated high velocity, high-acceleration, and yet, small-
amplitude head movements while the patient is instructed to stare at a stationary target 
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located at center gaze. If the VOR is intact, the patient will be able to maintain foveal 
vision of the target during the head impulse. If the VOR is impaired, rotation of the head 
toward the ipsilesional semicircular canal will drive the eyes off the target, forcing the 
patient to generate a volitional catch-up saccade to bring eyes back to the target [40] 
(Figures 7 and 8).
The receptor of the angular VOR is the crista ampullaris. This structure consists of both type 
I and type II hair cells as well as regularly and irregularly discharging afferent neurons. Type 
I hair cells populate the central part of the crista ampullaris. Irregular afferents primarily 
connect to type I hair cells or a mixture of type I and type II. These hair cells encode high-
frequency, high-acceleration head movements. Type II cells populate the periphery of the 
crista. Regular afferents carry the output of type II hair cells or a mixture of type I and type II 
and likely encode low-frequency, low acceleration movement [44, 45].
Figure 7. VHIT : Speed of the head in black = speed the eyes in green. There is no record of corrective saccades. (Figure 
provided by borgesdecarvalhootorrinos.com.br).
Figure 8. VHIT: Lower eye velocity than head. Presence of saccades. (Figure provided by borgesdecarvalhootorrinos.
com.br).
Electrophysiology in Ménière’s Disease
http://dx.doi.org/10.5772/intechopen.69668
93
Tsuji et al. reported that although MD affected the structure and function of type II hair cells, 
the density and number of type I hair cells appeared unchanged in patients with MD [46].
Maire and van Melle showed that, in early stages of MD, VOR gain was higher when the 
patient was rotated toward the affected ear, but this observed enhancement diminished as the 
disease progressed [47].
McCaslin et al. presented three cases of patients with Ménière’s disease with asymptomatic 
vestibular dysfunction demonstrated with videonystagmography (VNG) testing, which pro-
vided a quantitative measure of VOR gain. The authors found a dissociation between the 
caloric test and VHIT results, and they explained these findings by understanding the differ-
ent dynamic response properties of the two primary populations of neurons in the crista [40].
The assessment of cochlear function with audiometry, EcochG and CHAMP, of the sac-
cule through cervical VEMP, of the utricle through ocular VEMP, of the lateral semicircular 
canal with the caloric tests, and all of the semicircular canals by the vHIT demonstrates the 
advancements of research in the vestibular diagnosis. New paths are open to the discovery 
of the pathophysiological mechanism of a disease that was first described over a century ago 
and still has no defined treatment protocol.
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